Salute e Benessere

KHB Highlights the Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer…

Compact Footprint and Workflow Efficiency Compact Footprint and Workflow Efficiency Despite its small 0.36 m² footprint, the Polaris V150 delivers 150 tests per hour, enabling laboratories to achieve high operational efficiency within limited workspace. It supports continuous loading of samples, reagents, and reaction cups, while its STAT function ensures urgent samples are prioritized for rapid clinical decision-making. The system offers 40 sample positions, accommodates serum and plasma,...
PR Newswire
19/11/2025

European study shows falling prices, rising costs and shortages - findings from…

In the context of AMR Awareness Week, Viatris Inc. (Nasdaq: VTRS), a global healthcare company, with Medicines for Europe – the voice of the generic, biosimilar, and value-added medicines industries in Europe – present findings from a from an independent study by New Angle, a consulting and research agency, investigating the reasons behind shortages of essential off-patent medicines, with a particular focus on antibiotics. In the context of AMR Awareness Week,Viatris Inc. (Nasdaq: VTRS), a...
PR Newswire
19/11/2025

Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK Receives…

As Piramal Pharma Solutions' dedicated antibody-drug conjugate (ADC) development and manufacturing facility, Grangemouth offers comprehensive solutions for bioconjugates, from process development to scale-up. The site also plays a critical role in the ADCelerate™ program, which streamlines the path from R&D to GMP production to bring lifesaving bioconjugate therapies to patients in the clinic faster. As Piramal Pharma Solutions' dedicated antibody-drug conjugate (ADC) development and...
PR Newswire
19/11/2025

Essity awarded EcoVadis Platinum medal for outstanding sustainability leadership…

EcoVadis' rigorous methodology rewards not only strong policies but also measurable actions and results. For Essity's key focus areas affecting its business, the sustainability rating reflects comprehensive policies on all key areas, including disclosure on progress toward the UN Sustainable Development Goals (SDGs). EcoVadis' rigorous methodology rewards not only strong policies but also measurable actions and results. For Essity's key focus areas affecting its business, the sustainability...
PR Newswire
19/11/2025

European Commission approves Roche’s Lunsumio subcutaneous for relapsed or…

Lunsumio provides high rates of deep and long-lasting responses in third-line and later follicular lymphoma, a disease that typically becomes harder to treat each time a patient relapses 1,2 Lunsumio subcutaneous offers a new treatment option that can significantly reduce administration time to approximately one minuteAvailability of Lunsumio SC allows patients to receive treatment aligned to clinical requirements and lifestyle preferencesBasel, 19 November 2025 - Roche (SIX: RO,...
Nasdaq GlobeNewswire
19/11/2025

Rafa Laboratories Awarded up to $186 Million by BARDA to Develop a Life-Saving…

Addressing the Critical Window to Save Lives Addressing the Critical Window to Save Lives Uncontrolled bleeding is the leading cause of preventable death following trauma, whether caused by accidents, mass-casualty events or in the battlefield. Caregivers need a tool which can be easily administered to a large number of casualties in a short period of time. TXA is an antifibrinolytic agent commonly used off label around the world to treat trauma bleeding in the pre-hospital and...
PR Newswire
19/11/2025

Wearable Medical Devices Market Will reach $184.75 billion by 2033 - Strategic…

This surge is also being fuelled by a fundamental shift in patient expectations. Individuals want more visibility into their own health metrics, and healthcare systems-facing workforce shortages and rising costs-need technologies that improve monitoring efficiency without compromising care quality. Against this backdrop, wearable medical devices have emerged as a cornerstone of the modern healthcare ecosystem, offering unprecedented data precision, clinical relevance, and accessibility. This...
PR Newswire
19/11/2025

New data on lecanemab to be presented at CTAD conference

Key lecanemab poster presentation: Key lecanemab poster presentation: Real-world experience: During the poster session onMonday, Dec. 1, at3:00 PM PTandTuesday, Dec. 2, at5:30 PM PT, Poster 055 presents an overview of baseline characteristics and preliminary safety findings from a study of lecanemab in Alzheimer's disease (AD) using the ALZ-NET registry. Additional lecanemab poster presentations Leqembi is the result of a long-standing collaboration between BioArctic...
PR Newswire
19/11/2025

Europe must embed patient voices to transform digestive health outcomes, urges…

"Digestive diseases affect millions of people across Europe and place significant strain on patients, families, and healthcare systems," said Professor Patrizia Burra, Chair of the UEG Public Affairs Group. "This manifesto calls for a culture of partnership – where patients' lived experiences guide research priorities, policy decisions, and clinical practice." "Digestive diseases affect millions of people acrossEuropeand place significant strain on patients, families…
PR Newswire
19/11/2025

Osteoporosis Market Set to Expand Significantly During the Forecast Period…

Osteoporosis Market Summary Osteoporosis Market Summary Discover the osteoporosis new treatment @New Treatments for Osteoporosis Key Factors Driving the Growth of the Osteoporosis Market Rising Prevalence of Osteoporosis The global burden of osteoporosis is increasing rapidly due to the growing elderly population, especially among postmenopausal women. As life expectancy rises, the prevalence of age-related bone loss and fragility fractures continues to drive the...
PR Newswire
18/11/2025

Jazz Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference

About Jazz PharmaceuticalsJazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and…
PR Newswire
18/11/2025

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial…

Attachment notification-of-managers-transaction-lionel-carnot-november 2025
Nasdaq GlobeNewswire
18/11/2025

Genmab Announces Pricing of Private Offering of Senior Secured Notes and Senior…

Media ReleaseCOPENHAGEN, Denmark; November 18, 2025Genmab A/S (Nasdaq: GMAB) (“Genmab”) announced today that it and its wholly owned subsidiary Genmab Finance LLC (“Genmab Finance”) have priced their previously announced offering of $1.5 billion of 6.250% senior secured notes due 2032 (the “Secured Notes”) and $1.0 billion of 7.250% senior unsecured notes due 2033 (the “Unsecured Notes,” and together with the Secured Notes, the “Notes”). The issue price of the Notes is 100.000%...
Nasdaq GlobeNewswire
18/11/2025

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Company AnnouncementCOPENHAGEN, Denmark; November 18, 2025 –Genmab A/S(Nasdaq: GMAB) will increase its share capital by 32,059 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1:10,033 shares at DKK 1,025.00, 310 shares at DKK 1,147.50, 1,478 shares at DKK 1,161.00, 5,847...
Nasdaq GlobeNewswire
18/11/2025

Velico Announces Major Expansion of Manufacturing and Supply Chain Operations

The FrontlineODP™ decentralized manufacturing model envisions a global network of hundreds of blood centers, each capable of drying tens of thousands of plasma units annually. Planned adoption by leading military and civilian blood centers is accelerating across North America, Europe, and the Indo-Pacific. The combined production from installed and contracted FrontlineODP™ manufacturing systems is already expected to exceed 100,000 units per year. The FrontlineODP™ decentralized manufacturing...
PR Newswire
18/11/2025

Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and…

Company Announcement EPKINLY plus rituximab and lenalidomide (EPKINLY + R 2 ) is the first and only bispecific-based therapy approved by the FDA for follicular lymphoma in the second-line settingIn the Phase 3 EPCORE ®FL-1 trial, fixed duration EPKINLY + R 2demonstrated significantly superior progression-free survival and overall response rates compared to standard of care R 2,with approximately three out of four patients achieving a complete responseThis...
Nasdaq GlobeNewswire
18/11/2025

In-vitro fertilization services in US Market to Reach $8,186.08 Million by 2027…

Request Sample of the Report on Bariatric Beds Market Forecast 2032 -https://www.alliedmarketresearch.com/request-sample/3491 Request Sample of the Report on Bariatric Beds Market Forecast 2032 -https://www.alliedmarketresearch.com/request-sample/3491 These services are widely utilized by couples facing fertility challenges due to medical, lifestyle, or age-related factors. Increasing cases of infertility, rising maternal age, delayed pregnancies, and growing awareness about...
PR Newswire
18/11/2025

European Commission Approves BRINSUPRI® (brensocatib) as the First and Only…

— BRINSUPRI Was Reviewed Under EMA's Accelerated Assessment Pathway as It Is Considered of Major Interest for Public Health — — BRINSUPRI Was Reviewed Under EMA's Accelerated Assessment Pathway as It Is Considered of Major Interest for Public Health — BRIDGEWATER, N.J., Nov. 18, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver therapies to transform the lives of patients facing serious diseases, today...
PR Newswire
18/11/2025

MiRNA Microarray Kits And Reagents Market Surges to USD 2.45 Billion by 2033…

Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=843532&utm_source=PRNewswire&utm_medium=360 Download PDF Brochure:https://www.verifiedmarketreports.com/download-sample/?rid=843532&utm_source=PRNewswire&utm_medium=360 Browse in-depth TOC on MiRNA Microarray Kits And Reagents Market 202 - Pages 126 – Tables 37 – Figures Scope of The MiRNA Microarray Kits And Reagents Market Report Global MiRNA Microarray Kits And Reagents...
PR Newswire
18/11/2025

Animal Health Industry Poised for Explosive Growth - Forecasts Hit $112.33B by…

Download a free sample copy for more Insights on this report: Animal Health Market Download a free sample copy for more Insights on this report:Animal Health Market The growing rate of pet ownership offers an opportunity in the market. For instance, 62% of UK residents own pets. In addition, the focus on pet humanization and routine check-ups increases the adoption of animal health services. The presence of wellness products, vaccines, and surgery services helps in treating them well...
PR Newswire
18/11/2025

Metabolic Disorders Therapeutics Market Poised to Grow from US$74.97 Billion in…

Growth Outlook: A Convergence of Need and Innovation Growth Outlook: A Convergence of Need and Innovation Buy This Report with Year-End Offer ( Buy 1 report: Get 30% OFF | Buy 2 reports: Get 50% OFF each! Limited time offer):https://www.datamintelligence.com/buy-now-page?report=metabolic-disorders-therapeutics-market Segment Insights: What is Driving Revenue? By Drug Type By Application By Route of Administration Request for Customized Sample Report as per...
PR Newswire
18/11/2025

Urology Devices Market worth US$46.26 billion by 2030 with 6.0% CAGR |…

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173062212 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173062212 Browse in-depth TOC on "Urology Devices Market" 312 - Tables 50 - Figures 321 - Pages By product category,the global urology devices market is segmented into instruments and consumables & accessories. The instruments segment accounted for the largest share of the urology devices market...
PR Newswire
18/11/2025

IMed Group appoints Parminder Kalle as Chief Commercial Officer

OutspokenPR
18/11/2025

Hyland and Tribun Health partner to deliver next-generation, intelligent digital…

"This partnership between Hyland and Tribun Health positions healthcare organizations at the forefront of agentic digital pathology," said Michael Campbell, chief product officer at Hyland. "Together, we're setting a new standard for data-driven diagnostics, delivering faster, more precise diagnoses and improving patient outcomes; while reinforcing our shared commitment to driving innovation in healthcare." "This partnership between Hyland and Tribun Health positions…
PR Newswire
18/11/2025
Altri  Comunicati